Company Analysis
Sign in

Apogee Therapeutics, Inc. (APGE)

APGE · Biological Products, (No Diagnostic Substances) · Waltham, MA · filing with the SEC since 2023
Full chart Alerts Compare
Grade4.4
◀ Past 3.7● Present 5.3▶ Future 4.1
8 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

1 patent granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Apogee Therapeutics, Inc.’s names, not what it holds today.

Patents granted
1
1 utility, 1976 to Dec 31, 2025
Granted in 2025
1
in the last year the record reads
Applications published
1
1 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Apogee Therapeutics, Inc. its own name
US, as the owner printed on each patent
1 granted
0 published
Apogee Therapeutics, Inc. its own name
named as the applicant on its applications, in US
0 granted
1 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Jul 15, 202512,358,979Antibodies that bind interleukin 13 and methods of usePharmaceuticalsApogee Therapeutics, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Dec 4, 20252025/0368733ANTIBODIES THAT BIND INTERLEUKIN 13 AND METHODS OF USEPharmaceuticalsApogee Therapeutics, Inc.
What it applied for, 2024 to 2025: Pharmaceuticals 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton APGE · research, not advice